FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

31552711000001107: Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Mar 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
250841000001111 Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
250851000001114 Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Is a Lumacaftor 200mg / Ivacaftor 125mg tablets 112 tablet true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has AMP Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has specific active ingredient Lumacaftor false Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has specific active ingredient Ivacaftor true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Orkambi 200mg/125mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 112 tablet 4 x 28 tablets Has specific active ingredient Lumacaftor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start